Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT02251275 · COMPLETED
Trial details
- NCT number
- NCT02251275
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-17
- Primary completion
- 2018-11-09
- Enrollment
- 1803
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.